Lv11
38 积分 2022-02-17 加入
Lutetium177-Labeled DOTA-Ibandronate: A Novel Radiopharmaceutical for Targeted Treatment of Bone Metastases
1个月前
已完结
Engineering CD3/CD137 dual specificity into a DLL3-targeted T-cell engager enhances T-cell infiltration and efficacy against small cell lung cancer
3个月前
已完结
Abiraterone acetate plus prednisone versus placebo plus prednisone in chemotherapy-naive men with metastatic castration-resistant prostate cancer (COU-AA-302): final overall survival analysis of a randomised, double-blind, placebo-controlled phase 3 study
7个月前
已完结
Use of real‐world evidence in regulatory decisions for rare diseases in the United States—Current status and future directions
2年前
已完结
POSA272 Using Real World Evidence to Characterise Utility in Patients with a Rare Disease: Analysis of Pompe Registry Data
2年前
已完结
Using real world data to support regulatory approval of drugs in rare diseases: A review of opportunities, limitations & a case example
2年前
已完结
皖公网安备34019202002308
